We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Vaccine panel urges extra safety towards RSV, meningitis and chikungunya
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Vaccine panel urges extra safety towards RSV, meningitis and chikungunya
Vaccine panel urges extra safety towards RSV, meningitis and chikungunya
Health

Vaccine panel urges extra safety towards RSV, meningitis and chikungunya

Last updated: April 17, 2025 5:30 pm
Editorial Board Published April 17, 2025
Share
SHARE

by I. Edwards

A panel of federal well being consultants on Wednesday advisable expanded vaccine choices for a number of illnesses, together with respiratory syncytial virus (RSV), meningitis and a mosquito-borne sickness referred to as chikungunya.

The panel, often called the Advisory Committee on Immunization Practices (ACIP), makes vaccine use suggestions to the director of the U.S. Facilities for Illness Management and Prevention (CDC), The Related Press reported.

These suggestions are nearly at all times accredited. However current management modifications on the CDC could complicate subsequent steps.

Performing Director Susan Monarez, who’s President Donald Trump’s choose to steer the CDC, awaits U.S. Senate affirmation. Till that occurs, she has recused herself from common duties as a result of federal regulation concerning vaccines.

In keeping with two CDC officers who spoke anonymously, selections could now fall to U.S. Well being Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist.

The brand new suggestions embody:

Adults aged 50 to 59 with sure well being issues, like coronary heart illness, diabetes or persistent obstructive pulmonary dysfunction ought to have the ability to get the RSV shot.
A brand new mixture vaccine from GSK was endorsed. It protects towards 5 varieties of meningococcal micro organism, together with one linked to school campus outbreaks about 10 years in the past.
A second vaccine for chikungunya was advisable for vacationers age 12 and older heading to international locations with present outbreaks. About 100 to 200 instances of chikungunya are reported annually amongst U.S. vacationers.
A security warning was added to an older chikungunya vaccine that makes use of a weakened reside virus. Folks 65 and older ought to talk about the dangers with their physician, particularly in the event that they produce other well being situations. This follows reviews of six older adults growing coronary heart or mind signs shortly after getting the shot. The instances are nonetheless being investigated.

Extra data:
Be taught extra about vaccines on the Mayo Clinic.

© 2025 HealthDay. All rights reserved.

Quotation:
Vaccine panel urges extra safety towards RSV, meningitis and chikungunya (2025, April 17)
retrieved 17 April 2025
from https://medicalxpress.com/information/2025-04-vaccine-panel-urges-rsv-meningitis.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

New guidelines for beauty injectables intention to make the {industry} safer. Will they work?

Resident-to-resident aggression is frequent in nursing properties. This is how we are able to enhance residents’ security

Higher planning can cut back illness absence amongst shift staff

New AI instrument reimagines infectious illness forecasting, outperforms present state-of-the-art strategies

Lengthy-lasting HIV prevention shot headed towards approval

TAGGED:chikungunyaMeningitispanelProtectionRSVurgesvaccine
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Section III trial exhibits new therapy boosts remedy price for most typical type of breast most cancers
Health

Section III trial exhibits new therapy boosts remedy price for most typical type of breast most cancers

Editorial Board January 28, 2025
As Officials Look Away, Hate Speech in India Nears Dangerous Levels
Garth Hudson, co-founder and keyboardist of the Band, dies at 87
Trump Officials Failed to Provide Accounting of Foreign Gifts
British Terrorist Receives Life Sentence for Role in Americans’ Deaths

You Might Also Like

Girls much less prone to obtain therapy for lethal coronary heart situation
Health

Girls much less prone to obtain therapy for lethal coronary heart situation

June 7, 2025
Single-dose CAR-T remedy doubtlessly healing in a number of myeloma
Health

Single-dose CAR-T remedy doubtlessly healing in a number of myeloma

June 7, 2025
New analysis hyperlinks pores and skin barrier dysfunction to pediatric eosinophilic esophagitis
Health

New analysis hyperlinks pores and skin barrier dysfunction to pediatric eosinophilic esophagitis

June 7, 2025
Nurses cite staffing shortages, language limitations, and revenue focus as key care challenges
Health

Nurses cite staffing shortages, language limitations, and revenue focus as key care challenges

June 7, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?